🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New #JITC position article and guidelines: Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors bit.ly/3LFUwJt Justin Gainor Omid Hamid MD Michael Hurwitz Roberta Zappasodi Hussein Tawbi, MD, PhD Elad Sharon

Join us on May 1st-2nd for our Annual Update in Cancer Immunotherapy! Virtual and in-person options available! Expert faculty spanning basic, translational and clinical investigation. Mass General Cancer Center cpd.partners.org/content/advanc…

Thanks so much Edwin L. Steele Laboratories for your support of this course since its inception! Always a pleasure to hear incredible insights from Dr. Jain Mass General Cancer Center

Countdown to "Advances in Cancer Immunotherapy: Annual Update." Less than one month away (May 1-2 at the Westin Copley Place in Boston). Register now! Mass General Cancer Center MassGeneral Medicine cpd.partners.org/content/advanc…

Join us from 5/1-5/2 and hear from this impressive lineup: Justin Gainor Jeremy Abramson, MD Steve Blum Genevieve Boland, MD, PhD Florian J. Fintelmann Howard Kaufman Katie Keane @megcamps Laura Petrillo 🗽 Alexandra-Chloé Villani Lab...and more! 👉 bit.ly/41dF8br

Thanks so much for joining Jason Luke, MD, FACP Phenomenal pan-cancer overview of IO biomarkers and great tumor board discussion on neoadjuvant/adjuvant IO across disciplines!

Come on down to ⁦James ‘Jimmy’ Hills⁩ Your Healthy Java health fair at Thelma Burns building in #roxbury to learn about great preventive health care, Cancer screening and care! Having a great time! ⁦Rick Lee 이재방⁩ ⁦Mass General Cancer Center⁩ ⁦MGH Equity and Community Health⁩

Getting a late start to #ASCO2023 this year. Great to see so many lifelong friends Harvard Medical School class reunion #classof2008

Superstar fellow Alissa Cooper, MD of MGH Thoracic Oncology presents initial results from the global RETgistry of >100 post RET TKI biopsies to define mechanisms of resistance #happylungs JessicaJLinMD Alexander Drilon MD RETpositive RET Renegades Memorial Sloan Kettering Cancer Center

Fantastic presentations by MGH Thoracic Oncology team members JessicaJLinMD and Zosia Piotrowska at #ASCO2023 outlining mechanisms of resistance and next gen targeted therapies

We love our #ASCO23 host Marina Garassino! Enriqueta Felip Solange Peters Delvys Rodriguez Abreu Lizza Hendriks Heather Wakelee arsela prelaj Claudia rossanaberardi Giulia pasello Luis Paz-Ares Martin Reck Noemi Reguart Anne-Marie Dingemans Christian Rolfo Justin Gainor d.planchard charocampelo

#ESMOVirtualPlenary: Join us for the latest data in #LungCancer 👉 RATIONALE-315: EFS & OS of neoadjuvant tislelizumab (TIS) plus chemotherapy with adjuvant TIS in resectable #NSCLC. ⏲️ 15 & 16 Feb. ow.ly/ikMQ50Qvlwj Marina Garassino Luis Paz-Ares Justin Gainor AACR

Join course directors Justin Gainor, Krista Rubin, & Ryan Sullivan on Nov. 14-15 to learn more about the advances taking place in the immuno-oncology field. New this year: optional session on Immunotherapy Toxicities. #cancer #immunotherapy Register Now! cpdlearn.massgeneralbrigham.org/course/advance…

In the upcoming Clinical Development Strategies: Beyond Clinical Trials program, you'll have the opportunity to learn from renowned faculty like @SYShaw, Justin Gainor, and Anupam Jena. Register by September 12. buff.ly/4cqnqaW

Now online in Cancer Discovery: T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study - by Justin Gainor and colleagues doi.org/10.1158/2159-8… Mass General Brigham Moderna

Join me and our amazing faculty at our annual CME - "Advances in Cancer Immunotherapy" on Nov 14-15th. Registration is now open. This course has something from everyone! Mass General Cancer Center Harvard Medical School cpdlearn.massgeneralbrigham.org/course/advance…